Authors:
Koiwa, H
D'Urzo, MP
Assfalg-Machleidt, I
Zhu-Salzman, K
Shade, RE
An, HJ
Murdock, LL
Machleidt, W
Bressan, RA
Hasegawa, PM
Citation: H. Koiwa et al., Phage display selection of hairpin loop soyacystatin variants that mediatehigh affinity inhibition of a cysteine proteinase, PLANT J, 27(5), 2001, pp. 383-391
Authors:
Friebel, A
Ilchmann, H
Aelpfelbacher, M
Ehrbar, K
Machleidt, W
Hardt, WD
Citation: A. Friebel et al., SopE and SopE2 from Salmonella typhimurium activate different sets of RhoGTPases of the host cell, J BIOL CHEM, 276(36), 2001, pp. 34035-34040
Authors:
Schaschke, N
Assfalg-Machleidt, I
Machleidt, W
Lassleben, T
Sommerhoff, CP
Moroder, L
Citation: N. Schaschke et al., beta-cyclodextrin/epoxysuccinyl peptide conjugates: new drug targeting system for tumor cells, BIOORG MED, 10(7), 2000, pp. 677-680
Authors:
Muehlenweg, B
Assfalg-Machleidt, I
Parrado, SG
Burgle, M
Creutzburg, S
Schmitt, M
Auerswald, EA
Machleidt, W
Magdolen, V
Citation: B. Muehlenweg et al., A novel type of bifunctional inhibitor directed against proteolytic activity and receptor/ligand interaction - Cystatin with a urokinase receptor binding site, J BIOL CHEM, 275(43), 2000, pp. 33562-33566
Authors:
Randak, C
Auerswald, EA
Assfalg-Machleidt, I
Reenstra, WW
Machleidt, W
Citation: C. Randak et al., Inhibition of ATPase, GTPase and adenylate kinase activities of the secondnucleotide-binding fold of the cystic fibrosis transmembrane conductance regulator by genistein, BIOCHEM J, 340, 1999, pp. 227-235